- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of RASSF1A methylation in human malignancies
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 113, Issue 3, Pages 372-381
Publisher
Springer Nature
Online
2015-07-10
DOI
10.1038/bjc.2015.221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of RASSF1A Promoter Methylation with Lung Cancer Risk: a Meta-analysis
- (2015) Ying-Ze Huang et al. Asian Pacific Journal of Cancer Prevention
- Retracted: Promoter Methylation of theRASSF1AGene may Contribute to Colorectal Cancer Susceptibility: A Meta-Analysis of Cohort Studies
- (2014) He-Ling Wang et al. ANNALS OF HUMAN GENETICS
- Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting
- (2014) Xuesong Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer
- (2014) Kirill Litovkin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic Value of RASSF1 Promoter Methylation in Prostate Cancer
- (2014) Kristina Daniunaite et al. JOURNAL OF UROLOGY
- RETRACTED ARTICLE: Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis
- (2014) He-Ling Wang et al. MOLECULAR BIOLOGY REPORTS
- RETRACTED ARTICLE: Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies
- (2014) Yong-Shuang Li et al. MOLECULAR BIOLOGY REPORTS
- Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis
- (2014) Stine A. Danielsen et al. NEURO-ONCOLOGY
- RASSF1A Promoter Hypermethylation Is a Strong Biomarker of Poor Survival in Patients with Salivary Adenoid Cystic Carcinoma in a Chinese Population
- (2014) Chun-Ye Zhang et al. PLoS One
- Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China
- (2013) Sheng Li Zhou et al. BMC CANCER
- Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I-II Non-Small Cell Lung Cancer
- (2013) E. Ko et al. CLINICAL CANCER RESEARCH
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- Methylation status and protein expression of RASSF1A in breast cancer patients
- (2013) Hoda A. Hagrass et al. MOLECULAR BIOLOGY REPORTS
- Molecular genetic testing and the future of clinical genomics
- (2013) Sara Huston Katsanis et al. NATURE REVIEWS GENETICS
- RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients
- (2013) Shohei Honda et al. PEDIATRIC SURGERY INTERNATIONAL
- Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population
- (2013) Rupal Sinha et al. PLoS One
- The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies
- (2013) Yu-Zheng Ge et al. TUMOR BIOLOGY
- Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis
- (2013) Dong-Tao Shi et al. TUMOR BIOLOGY
- Association of RASSF1A genotype and haplotype with the progression of clear cell renal cell carcinoma in Japanese patients
- (2012) Yoshihisa Kawai et al. BJU INTERNATIONAL
- Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
- (2012) Jia Xu et al. BMC CANCER
- A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma
- (2012) K. S. Yee et al. CANCER RESEARCH
- Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer
- (2012) Demao Yao et al. CLINICA CHIMICA ACTA
- An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial
- (2012) F. de Fraipont et al. CLINICAL CANCER RESEARCH
- Ras Association Domain Family 1A: A Promising Prognostic Marker in Recurrent Nonmuscle Invasive Bladder Cancer
- (2012) Ji Sang Kim et al. Clinical Genitourinary Cancer
- RASSF1A Ala133Ser polymorphism is associated with increased susceptibility to hepatocellular carcinoma in a Turkish population
- (2012) Süleyman Bayram GENE
- Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
- (2012) Ayelet Avraham et al. INTERNATIONAL JOURNAL OF CANCER
- Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor
- (2012) Junjiro Ohshima et al. PEDIATRIC BLOOD & CANCER
- Relationship between Tumor DNA Methylation Status and Patient Characteristics in African-American and European-American Women with Breast Cancer
- (2012) Songping Wang et al. PLoS One
- The Prognostic Role of RASSF1A Promoter Methylation in Breast Cancer: A Meta-Analysis of Published Data
- (2012) Yong Jiang et al. PLoS One
- The Association of RAS Association Domain Family Protein1A (RASSF1A) Methylation States and Bladder Cancer Risk: A Systematic Review and Meta-Analysis
- (2012) Tianyi Gao et al. PLoS One
- Hypermethylation-modulated Downregulation of RASSF1A Expression Is Associated with the Progression of Esophageal Cancer
- (2011) Wei-min Mao et al. ARCHIVES OF MEDICAL RESEARCH
- Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients
- (2011) Yoon Hee Cho et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
- (2011) Georg Göbel et al. BREAST CANCER RESEARCH AND TREATMENT
- Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma
- (2011) J. Stutterheim et al. CLINICAL CANCER RESEARCH
- Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour
- (2011) Yasuyuki Okamoto et al. GUT
- Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
- (2011) Céline Montavon et al. GYNECOLOGIC ONCOLOGY
- Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression
- (2011) Liyang Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Gene expression profiling in breast cancer: classification, prognostication, and prediction
- (2011) Jorge S Reis-Filho et al. LANCET
- Alterations of RASSF1A in premalignant cervical lesions: Clinical and prognostic significance
- (2011) Sraboni Mitra et al. MOLECULAR CARCINOGENESIS
- Inactivation of RASSF1A, RARβ2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma
- (2010) Ali Fendri et al. CANCER BIOLOGY & THERAPY
- The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis
- (2010) Jun Wang et al. CARCINOGENESIS
- Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma
- (2009) Y. Kawai et al. ANNALS OF ONCOLOGY
- Aberrant CpG Island Hypermethylation of RASSF1A in Gastric Cardia Adenocarcinoma
- (2009) Wei Guo et al. CANCER INVESTIGATION
- Methylation of RASSF1A, RASSF2A, and HIN-1 Is Associated with Poor Outcome after Radiotherapy, but not Surgery, in Oral Squamous Cell Carcinoma
- (2009) K.-H. Huang et al. CLINICAL CANCER RESEARCH
- CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- (2009) A. Tanemura et al. CLINICAL CANCER RESEARCH
- Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
- (2009) Wieslawa Niklinska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients
- (2009) Sondes Karray-Chouayekh et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- DNA methylation in small lung adenocarcinoma with bronchioloalveolar carcinoma components
- (2009) Takafumi Kubo et al. LUNG CANCER
- Effect of aberrant promoter methylation ofFHITandRASSF1Agenes on susceptibility to cervical cancer in a North Indian population
- (2008) M. Kausar Neyaz et al. BIOMARKERS
- DNA Methylation in Benign Breast Epithelium in Relation to Age and Breast Cancer Risk
- (2008) D. M. Euhus et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- RASSF1A Polymorphism A133S Is Associated with Early Onset Breast Cancer in BRCA1/2 Mutation Carriers
- (2008) B. Gao et al. CANCER RESEARCH
- Quantitative Promoter Hypermethylation Analysis of Cancer-Related Genes in Salivary Gland Carcinomas: Comparison with Methylation-Specific PCR Technique and Clinical Significance
- (2008) E.-S. Lee et al. CLINICAL CANCER RESEARCH
- Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma
- (2008) K. C. A. Chan et al. CLINICAL CHEMISTRY
- Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus
- (2008) Y. T. Kim et al. DISEASES OF THE ESOPHAGUS
- Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis
- (2008) Susmita Ghosh et al. INTERNATIONAL JOURNAL OF CANCER
- The methylation status ofRASSF1Apromoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients
- (2008) Shohei Honda et al. INTERNATIONAL JOURNAL OF CANCER
- Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis
- (2008) Xiaoyun Liao et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical significance of promoter hypermethylation of RASSF1A, RARβ2, BRCA1 and HOXA5 in breast cancers of Indian patients
- (2008) Sarangadhara Appala Raju Bagadi et al. LIFE SCIENCES
- Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma
- (2008) Judit Pallarés et al. MODERN PATHOLOGY
- DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
- (2008) Malcolm V. Brock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder Cancer
- (2008) Sonata Jarmalaite et al. ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started